Industry Profile
Nuclear Medicine and Radiopharmaceuticals
Target researchers — Radiochemists, nuclear medicine physicians, and medicinal chemists specializing in radiolabeling of targeting vectors, PET tracer design, radiopharmaceutical synthesis automation, SPECT/PET imaging biomarker validation, and targeted radionuclide therapy
Nuclear medicine uses radioactive isotopes attached to targeting molecules for diagnosis via PET and SPECT and therapy through targeted radionuclide therapy of cancer and neurological disease. University radiochemistry and medical physics departments develop new chelation chemistries, targeting peptides, and radiolabeling automation platforms that companies license for clinical radiopharmaceutical pipelines.
Key Companies
Use Cases
PET tracer precursor supply
Novel radionuclide-chelator licensing
Radiopharmaceutical synthesis automation
Alpha and beta-emitter radionuclide sourcing
Tumor-targeting vector co-development
GMP radiolabeling CRO services
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →